Partner Headlines - CPHD

  1. Baron Funds Comments on Cepheid

    GuruFocus
  2. Columbia Wanger Ups Stake in Fiesta Restaurant

    GuruFocus
  3. Cepheid Announces Diagnostic Collaboration With MedImmune And ...

    Benzinga
  4. Take Profits Judiciously When You're Short A Stock

    IBD
  5. Benzinga's Top Upgrades

    Benzinga
  6. FIND And Cepheid Announce A Strategic Collaboration To Advance ...

    Benzinga
  7. Benzinga's Top Downgrades

    Benzinga
  8. Mid-Morning Market Update: Markets Mostly Flat; General Motors ...

    Benzinga
  9. Benzinga's Top Downgrades

    Benzinga
  10. Mid-Afternoon Market Update: Colfax Drops On Weak Results; SanDisk ...

    Benzinga
  11. Mid-Day Market Update: Dow Drops Over 100 Points; TripAdvisor ...

    Benzinga
  12. Mid-Morning Market Update: Markets Gain; Bank of America Earnings ...

    Benzinga
  13. Morning Market Losers

    Benzinga
  14. Benzinga's Top #PreMarket Losers

    Benzinga
  15. Tuesday's After-Hours Movers Led By SanDisk, Cepheid, JPMorgan ...

    Benzinga
  16. Stocks Fall For Fourth Day On Global Growth Worries

    IBD
  17. Major Indexes Extend Losses; Sucampo Bucks Weakness

    IBD
  18. Morning Market Losers

    Benzinga
  19. Stocks On Pace For Fourth Straight Gain; GoPro Gains

    IBD
  20. Stocks Hold On To Most Gains; Biotechs Quicken Their Pulse

    IBD
  21. Stocks Lower In Late Trading, But Utilities Rally

    IBD
  22. Craig-Hallum Upgrades Cepheid To Buy

    Benzinga
  23. Morning Market Gainers

    Benzinga
  24. US Stock Futures Rise Ahead Of Earnings, Economic Data

    Benzinga
  25. Novartis, Verastem & Cepheid Making Biotech Headlines On Friday

    Benzinga
  26. Leading Medical Stock Cepheid Trying To Break Out

    IBD
  27. Benzinga's Top Upgrades

    Benzinga
  28. Bank of America Upgrades Cepheid To Buy

    Benzinga
  29. UPDATE: Citigroup Reiterates On Cepheid Following Positive Data

    Benzinga
  30. Top Medical Stocks: Cepheid Diagnostics Sales Strong

    IBD
  31. Cepheid Receives FDA Clearance For Xpert Norovirus, The First ...

    Benzinga
  32. CEPHEID

    IBD
  33. Cepheid Receives FDA Clearance For Xpert Flu/RSV XC

    Benzinga
  34. Cepheid To Develop Xpert Ebola For Countries Worst Hit By Epidemic

    Benzinga
  35. Several Sectors Emerge As Leaders Of New Market Uptrend

    IBD
  36. Stocks Fight Back To Finish Mixed

    IBD
  37. Dow, Nasdaq Battle Near Flat Line; Energy Weighs On S&P 500

    IBD
  38. Cepheid Explores Test For Ebola Disease; Q3 Beats

    IBD
  39. CEPHEID

    IBD
  40. Cepheid Extends Reach Of Direct US Commercial Operations

    Benzinga
  41. UPDATE: ISI Group Upgrades Cepheid

    Benzinga
  42. CEPHEID

    IBD
  43. LinkedIn, TripAdvisor, Google: Top Manager's Ideas

    IBD
  44. Alexion Takes Off On Outlook

    IBD
  45. Three Medical Tech Names To Watch In Healthcare Space

    IBD
  46. Align Leads Three Top-Rated Medical Equipment Stocks

    IBD
  47. UPDATE: JMP Securities Initiates Coverage on Cepheid on Market ...

    Benzinga
  48. Five Medical Stocks Leaders Trade Near New Highs

    IBD
  49. ViroPharma Gets Bought Out; Medicines Clears Entry

    IBD
  50. UPDATE: ISI Group Downgrades Cepheid on Key Drivers Constraining ...

    Benzinga
  51. Benzinga's Top Downgrades

    Benzinga
  52. UPDATE: Bank of America Downgrades Cepheid on Fair Valuation

    Benzinga
  53. Benzinga's Top Downgrades

    Benzinga
  54. Cepheid Reports Xpert MTB/RIF Categorized 'Moderate Complexity' ...

    Benzinga
  55. Cepheid Announces Board of Directors Changes

    Benzinga
  56. Cepheid's Chlamydia and N. Gonorrhoeae Test Categorized 'Moderate ...

    Benzinga
  57. Medtech Stocks Moving As Conference Makes Waves

    IBD
  58. Medtech Stocks Moving As Conference Makes Waves

    IBD
  59. Cepheid Offers Update on Xpert Test Availability, Sees Q4 Sales ...

    Benzinga
  60. UPDATE: Piper Jaffray Downgrades Cepheid to Neutral, Lowers PT

    Benzinga
  61. Oppenheimer Holdings Reiterates Outperform Rating, $43 PT on ...

    Benzinga
  62. Canaccord Genuity Reiterates Buy Rating, $50 PT on Cepheid

    Benzinga
  63. Cantor Fitzgerald Reiterates Hold Rating, $38 PT on Cepheid

    Benzinga
  64. US Stock Futures Down Ahead Of Economic Data

    Benzinga
  65. Stocks To Watch For December 28, 2012

    Benzinga
  66. UPDATE: Cepheid Wins FDA Clearance for Xpert CT/NG

    Benzinga
  67. UPDATE: Bank of America Initiates Cepheid at Buy on Prospects, ...

    Benzinga
  68. Look At That Base: If You Can't Name It, Don't Buy It

    IBD
  69. UPDATE: Goldman Sachs Downgrades Cepheid to Neutral on Lack of ...

    Benzinga
  70. Benzinga's Top Downgrades

    Benzinga
  71. Benzinga's Top Upgrades

    Benzinga
  72. CEPHEID Reports Operating Results (10-Q)

    GuruFocus
  73. UPDATE: Cantor Fitzgerald Maintains Cepheid at Hold on Analyst ...

    Benzinga
  74. UPDATE: Canaccord Genuity Reiterates Cepheid at Buy with $50 ...

    Benzinga
  75. Goldman Sachs Reiterates Buy Rating, $46 PT on Cepheid

    Benzinga
  76. UPDATE: ISI Group Reduces PT to $30.50 on Cepheid Post Analyst ...

    Benzinga
  77. Benzinga Mid-Afternoon Market Update

    Benzinga
  78. Stock Futures Point to Higher Open with Yahoo (YHOO) and Hewlett-Packard ...

    MarketIntelligenceCenter
  79. Benzinga Mid-Day Market Update

    Benzinga
  80. Mid-Morning Market Update

    Benzinga
  81. UPDATE: ISI Group Reduces PT to $32.50 on Cepheid Following Negative ...

    Benzinga
  82. Benzinga's Top Initiations

    Benzinga
  83. A Peek Into The Market Before The Trading Starts

    Benzinga
  84. UPDATE: JP Morgan Initiates Cepheid at Overweight on Growth Outlook

    Benzinga
  85. Benzinga's Top Initiations

    Benzinga
  86. Technology Sector Wrap

    FoxBusiness
  87. Technology Sector Wrap

    FoxBusiness
  88. Technology Sector Wrap

    FoxBusiness
  89. Analyst Downgrades: Cepheid, Intuitive Surgical, and Travelzoo

    SchaeffersResearch
  90. Cepheid Down 20% on Weak Guidance

    Benzinga
  91. CEPHEID (CPHD) CEO John L Bishop sells 40,201 Shares

    GuruFocus
  92. CEPHEID (CPHD) CEO John L Bishop sells 25,000 Shares

    GuruFocus
  93. CEPHEID (CPHD) EVP, CFO Andrew Miller sells 17,437 Shares

    GuruFocus
  94. A Peek Into The Market Before The Trading Starts

    Benzinga
  95. UPDATE: UBS Investment Research Upgrades Cepheid to Buy; Opportunistic ...

    Benzinga
  96. Benzinga's Top Downgrades With Color for May 14, 2012

    Benzinga
  97. UPDATE: GARP Research & Securities Downgrades Cepheid to Neutral; ...

    Benzinga
  98. Cepheid Earnings Miss Estimates; Stock Plummets

    IBD
  99. Cepheid Q1 Estimates Soft, But Outlook For Year Good

    IBD
  100. Zoll Deal, Intutive Surgical Lift Medical Equipment

    IBD
Trading Center